Australia · Delayed Price · Currency is AUD Australian Clinical Labs Statistics
Total Valuation
ASX:ACL has a market cap or net worth of AUD 416.02 million. The enterprise value is 708.47 million.
| Market Cap | 416.02M |
| Enterprise Value | 708.47M |
Important Dates
The last earnings date was Monday, February 16, 2026.
| Earnings Date | Feb 16, 2026 |
| Ex-Dividend Date | Mar 12, 2026 |
Share Statistics
ASX:ACL has 189.96 million shares outstanding. The number of shares has decreased by -6.51% in one year.
| Current Share Class | 189.96M |
| Shares Outstanding | 189.96M |
| Shares Change (YoY) | -6.51% |
| Shares Change (QoQ) | +9.03% |
| Owned by Insiders (%) | 2.61% |
| Owned by Institutions (%) | 92.82% |
| Float | 172.97M |
Valuation Ratios
The trailing PE ratio is 15.54 and the forward PE ratio is 12.54. ASX:ACL's PEG ratio is 1.65.
| PE Ratio | 15.54 |
| Forward PE | 12.54 |
| PS Ratio | 0.56 |
| PB Ratio | 2.75 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 2.65 |
| P/OCF Ratio | 2.53 |
| PEG Ratio | 1.65 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 3.48, with an EV/FCF ratio of 4.52.
| EV / Earnings | 26.93 |
| EV / Sales | 0.96 |
| EV / EBITDA | 3.48 |
| EV / EBIT | 10.32 |
| EV / FCF | 4.52 |
Financial Position
The company has a current ratio of 0.59, with a Debt / Equity ratio of 2.09.
| Current Ratio | 0.59 |
| Quick Ratio | 0.42 |
| Debt / Equity | 2.09 |
| Debt / EBITDA | 1.55 |
| Debt / FCF | 2.01 |
| Interest Coverage | 4.77 |
Financial Efficiency
Return on equity (ROE) is 16.68% and return on invested capital (ROIC) is 9.94%.
| Return on Equity (ROE) | 16.68% |
| Return on Assets (ROA) | 7.48% |
| Return on Invested Capital (ROIC) | 9.94% |
| Return on Capital Employed (ROCE) | 18.78% |
| Weighted Average Cost of Capital (WACC) | 6.83% |
| Revenue Per Employee | 156,913 |
| Profits Per Employee | 5,598 |
| Employee Count | 4,700 |
| Asset Turnover | 1.29 |
| Inventory Turnover | 28.26 |
Taxes
In the past 12 months, ASX:ACL has paid 14.93 million in taxes.
| Income Tax | 14.93M |
| Effective Tax Rate | 35.87% |
Stock Price Statistics
The stock price has decreased by -40.81% in the last 52 weeks. The beta is 1.01, so ASX:ACL's price volatility has been similar to the market average.
| Beta (5Y) | 1.01 |
| 52-Week Price Change | -40.81% |
| 50-Day Moving Average | 2.59 |
| 200-Day Moving Average | 2.68 |
| Relative Strength Index (RSI) | 32.67 |
| Average Volume (20 Days) | 1,070,696 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ASX:ACL had revenue of AUD 737.49 million and earned 26.31 million in profits. Earnings per share was 0.14.
| Revenue | 737.49M |
| Gross Profit | 270.17M |
| Operating Income | 68.65M |
| Pretax Income | 41.63M |
| Net Income | 26.31M |
| EBITDA | 81.58M |
| EBIT | 68.65M |
| Earnings Per Share (EPS) | 0.14 |
Balance Sheet
The company has 23.14 million in cash and 315.11 million in debt, with a net cash position of -291.98 million or -1.54 per share.
| Cash & Cash Equivalents | 23.14M |
| Total Debt | 315.11M |
| Net Cash | -291.98M |
| Net Cash Per Share | -1.54 |
| Equity (Book Value) | 151.04M |
| Book Value Per Share | 0.79 |
| Working Capital | -81.50M |
Cash Flow
In the last 12 months, operating cash flow was 164.57 million and capital expenditures -7.88 million, giving a free cash flow of 156.70 million.
| Operating Cash Flow | 164.57M |
| Capital Expenditures | -7.88M |
| Free Cash Flow | 156.70M |
| FCF Per Share | 0.82 |
Margins
Gross margin is 36.63%, with operating and profit margins of 9.31% and 3.57%.
| Gross Margin | 36.63% |
| Operating Margin | 9.31% |
| Pretax Margin | 5.64% |
| Profit Margin | 3.57% |
| EBITDA Margin | 11.06% |
| EBIT Margin | 9.31% |
| FCF Margin | 21.25% |
Dividends & Yields
This stock pays an annual dividend of 0.13, which amounts to a dividend yield of 5.76%.
| Dividend Per Share | 0.13 |
| Dividend Yield | 5.76% |
| Dividend Growth (YoY) | 2.00% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 92.80% |
| Buyback Yield | 6.51% |
| Shareholder Yield | 12.27% |
| Earnings Yield | 6.32% |
| FCF Yield | 37.67% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ASX:ACL has an Altman Z-Score of 2.76 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.76 |
| Piotroski F-Score | 7 |